Rheumatoid arthritis Flashcards

1
Q

Describe the structure of the normal synovium

A

It is a connective tissue made of 2 layers which lies between the joint space and joint capsule

Lining layer: Delicate CT facing joint space which is populated by macrophage like Type1/a synoviocytes and fibroblast like Type 2/b synoviocytes

Sublining: Loose CT with neurovasculature populated with macrophages and fibroblasts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the RA synovium

A

Angiogenesis and fibrosis - highly vascularised tissue
Hypetrophy of lining layer becomes 6-8 cells thick
Infiltration of tissue with inflammatory cells
Neutrophil extravasation
Joint swelling and distension
Increased chemokine production + upregulation of adhesion molecules on vascular endothelium
Pannus formation - almost metastatic like inflammation in end stage untreated disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the inflammation in RA

A

Unknown inflammatory trigger

Inflammatory cells infiltrate the synovium and proliferate, there is leukocyte extravasation mediated by chemotaxis

Inflammatory mediators make cells become more permeable and leaky

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe leukocyte extravasation

A

Margination + rolling

E selectin is secreted on the inside of the blood vessel walls which initiates rolling adhesion

Tight binding of leukocytes to CXCL8 on endothelium

Diapedesis : Leukocytes cross and penetrate endothelium mediated by PECAM

Leukocytes migrate out vessel and to areas of inflammation via chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does angiogenesis occur in RA?

A

= growth of new blood vessels from the host vasculature

  • Triggered by hypoxia
  • As the synovium becomes hypertrophied + hyper proliferates and grows it requires more O2 to sustain itself it hence becomes hypoxic
  • Hyoxia and increased metabolic demand/nutrient demand induces release of HIF which release pro angiogenic factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Increased chemokine/cytokine production ?

What is the role of TNFalpha?

A

Up regulation of adhesion molecules on vascular endothelium for rolling adhesion so more leukocyte recruitment

Increased cytokines activates MMPS to degrade matrix + cartilage
TNFalpha - activates vascular endothelium + MMPs, activate bone degradation by osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What secretes RANKL?

What is the importance of RANKL?

A

Fibroblasts

Activates osteoclasts to degrade the bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is pannus formation?

A

Hallmark of chronic RA inflammation, hypertrophied synovium, infiltration of immune cells, vascularised angiogenesis, increased cytokine/chemokines

Metastatic and invasive like process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of RF?

A

Clears immune complexes + uptake by B cells
lower specificity
IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are anti CCP antibodies ?

When may citrulline be produced?

A

90-95% specificity
They are auto antibodies in response to cyclic citrullinated peptides present in keratin, collagen, cartilage, fibrin.

Can be produced in post translational modification when enzyme PAD1 converts arginine -> citrulline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which HLA allele is associated with RA and what does it encode for?
Where is the shared epitope located?

A

HLA-DRB1 gene and the DRB1 allele which encodes for the shared epitope
Shared epitope is common to many auto immune disorders
It is common to all HLA-DRB1 alleles

Shared epitope is located in variable region of B1 domain in the cleft of MHCII. Variability in the cleft causes different antigen binding and altered contact strength between antigens and its receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the typical features of RA?

What can predict RA?

A
  • Symmetrical involvement
  • Systemic effects
  • Joint swelling, deformity and lack of function
  • Better on exercise worse on rest
  • Inflammatory - trigger unknown
  • MCP + MTP joints
  • Early morning stiffness

Family history and prior illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some systemic effects of RA?

A
  • Chest X ray: Sarcoidosis
  • Eye disease
  • Weight loss
  • Skin rashes
  • Psoriasis
  • Lupus
  • Raynauds - loss of vasodilatory NO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some clinical features of RA joints?

A

Pain, swelling and tenderness especially the MCP, MTP joints
Functional impairments: Reduced grip strength, inability to make a fist, incomplete elbow extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What diagnostic tests can aid RA diagnosis?

A

Liver function tests
Blood tests
Doppler ultrasounds - vascularised synovium
Ultrasound - synovitis, flexor tenosynovitis, erosions
X rays: Chest + hands/feet to observe erosion
Thyroid + glucose tests - prescribing medication
Urate - gout
Autoantibodies: RF, anti-ccp, anti nuclear antibody ( lupus)
CRP + ESR: Inflammatory markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why do we take X rays of both the chest + hands/feet?

A

Chest: Identify if other problems which typically present with joint problems e.g Lung cancer or sarcoidosis

Hands/feet: Joint space narrowing, osteophytes, erosion, osteopaenia

17
Q

What are some of the extra articular manifestations of RA?

A

Eyes: Dry eyes, episcleritis, scleritis
CVS: Pericarditis, pericardial effusions
Skin: Rashes, psoriasis
Nervous system: Carpal tunnel, neuropathy
Vascular: Vasculitis
Lungs: Fibrosis, pleural effusions, pulmonary nodules
Blood: Anaemia and thrombocytosis

18
Q

What are the main 4 aims of RA treatment?

A

Symptom control
Maximise function
Minimise pain + damage

19
Q

What are the main ways of treating RA?

What is triple therapy “treat to target approach”?

A

NSAIDS - anti inflammatory e.g Naproxen
DMARDS
Biological agents e.g TNF monoclonal antibodies
Analgesics e.g morphine
Steroids: Reduce inflammation

Triple therapy = hydroxychloroquine, methotrextate and sulfalazine. Is an agressive treatment to improve symptoms, marker of inflammation + disease progression

20
Q

What are biological agents?

Describe MOA of influximab

A

Agents that target specific immune molecules or cells

  • Binds to TNFalpha + inhibits its interaction with its receptor
  • Down regulation of pro inflammatory cytokines
  • Decreased leukocyte migration to injury sites
  • Apoptosis of cells producing TNFalpha